Clinical Trial Update: NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline [Phase 2]

View source ↗

Summary

Phase 2 trial update indicating the NEODOXy study is currently recruiting to test doxycycline as a strategy to target breast cancer stem cells. The trial is spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING